ELIZABETH SABELLA: Open Payments
NPI 1831832120 · ROANOKE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$576 in 11 payments from 11 companies in 2025. Trend: 2023 $15 · 2024 $660 · 2025 $576
Food & beverage: $576
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 1 | $150 |
| Novartis Pharmaceuticals Corporation | 1 | $127 |
| Alnylam Pharmaceuticals Inc. | 1 | $125 |
| ABIOMED | 1 | $38 |
| Boston Scientific Corporation | 1 | $36 |
| Merck Sharp & Dohme LLC | 1 | $19 |
| PFIZER INC. | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
Products named: Attruby, LEQVIO, AMVUTTRA, LUX-Dx Insertable Cardiac Monitor, VERQUVO, VYNDAQEL, EVKEEZA, ELIQUIS.
Industry payments across VA — which companies pay providers there.
